Ketanov

Ketorolac Trometamol, the active ingredient in Ketanov, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It provides short‑term relief of moderate to severe acute pain, including post‑operative pain, in adult patients, and is typically prescribed for up to five days to minimize risk of adverse events.

GNH USA supplies Ketanov as a licensed, GDP‑compliant international pharmaceutical product, sourced from EU manufacturers and distributed to hospitals, pharmacies and clinics worldwide, adhering to stringent quality and regulatory standards.

Ketanov (ketorolac trometamol) is used to manage pain by inhibiting prostaglandin synthesis in the cyclooxygenase pathway. - Moderate to severe acute pain: provides rapid analgesia for conditions such as renal colic or musculoskeletal injury. - Post‑operative pain: reduces pain intensity after surgical procedures, facilitating early mobilization. - Short‑term pain management: offers effective relief when non‑opioid therapy is required for up to five days.

Ketorolac trometamol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or dyspepsia: mild gastrointestinal upset. - Headache: transient head pain. - Dizziness: occasional vertigo or light‑headedness.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: risk of serious hemorrhage. - Acute kidney injury: rapid decline in renal function. - Severe hypersensitivity reactions: anaphylaxis or skin rash.

When prescribing Ketanov, clinicians should consider several precautionary measures to minimize risk. - Assess renal function: avoid use in patients with severe renal impairment or dehydration. - Evaluate bleeding risk: contraindicated in active gastrointestinal ulceration or coagulopathy. - Limit duration: restrict therapy to the shortest possible period, generally not exceeding five days. - Avoid concomitant NSAIDs: concurrent use increases risk of gastrointestinal and renal adverse events. - Monitor cardiovascular status: use cautiously in patients with known cardiovascular disease. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Ketorolac trometamol can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, direct oral anticoagulants): increased risk of bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for renal function decline when combined with NSAIDs. - Lithium: NSAIDs can raise lithium serum levels, requiring monitoring.